Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Read more
Colli Pee Novosanis

Our products

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Learn more
Colli-Pee postal kits for home collection

Home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Learn more

Latest news

View all news

Winner announcement of EACR & Novosanis Research Grant: Cancer Biomarker Detection in Urine

12/10/2021
We are pleased to announce that Dr Barbara Guinn from University of Hull UK is the winner of the EACR & Novosanis Grant for Cancer Biomarker Detection in Urine.
Read more

Latest blogpost

View all blogs

Urine as an emerging liquid biopsy for bladder cancer biomarker detection

Urine as an emerging liquid biopsy for bladder cancer biomarker detection

28/09/2021
Given the function of the bladder, and its proximity to the urinary tract, urine as a sample type is particularly attractive as it can contain potential biomarkers for bladder cancer detection.
Read more

Upcoming event

View all events

ISLB 2021

ISLB 2021

Virtual
Novosanis is excited to present a booth at ISLB, an international conference focusing on liquid biopsy. The congress takes place virtually on 22 October. Our team is excited to share the potential of urine as a liquid biopsy, especially in the field of oncology, during a presentation at the...
Read more